Tuberculosis

Featured

world-health-day-image

Accelerating an Integrated Approach to NCD Prevention and Control Globally

Dr. Samira Asma, Chief, Global NCD Program, CDC Over the past 18 years, I’ve worked with Ministries of Health and other partners in 180 countries to advance CDC’s overarching global health goals and accelerate strategies for the prevention and control of noncommunicable diseases (NCDs) and injuries. NCDs and injuries are responsible for millions of premature deaths, especially in low- and middle-income counties (LMICs). As public health practitioners, we have an important opportunity to work collaboratively to accelerate and scale up implementation of proven prevention and treatment strategies and measure their impact.

Image pmed.1001403.blog_.jpg

U.S. Must Increase Capacity For Global Health R&D, Anticipate Global Disease Threats

Washington Post: Why aren’t we producing medications for looming global disease threats? Mel Spigelman, physician and president and chief executive of TB Alliance “…[A new Global Health Technologies Coalition] analysis reveals that over the past six years, [U.S.] taxpayer funding for global health research has been stagnant or declining. … Managing health threats through emergency…More

kaiser foundation wiki

Kaiser Family Foundation Releases Fact Sheet On U.S. Govt & Global TB

Kaiser Family Foundation: The U.S. Government and Global Tuberculosis This updated fact sheet discusses U.S. government global TB efforts and funding, global statistics related to the disease, and international goals to control and treat TB (3/20).

Latest

Accelerating an Integrated Approach to NCD Prevention and Control Globally

world-health-day-image

Dr. Samira Asma, Chief, Global NCD Program, CDC Over the past 18 years, I’ve worked with Ministries of Health and other partners in 180 countries to advance CDC’s overarching global health goals and accelerate strategies for the prevention and control of noncommunicable diseases (NCDs) and injuries. NCDs and injuries are responsible for millions of premature deaths, especially in low- and middle-income counties (LMICs). As public health practitioners, we have an important opportunity to work collaboratively to accelerate and scale up implementation of proven prevention and treatment strategies and measure their impact.


Stakeholders Begin To Examine Funding Needs To Prevent, Treat Global Hepatitis Infections

Devex: Where should money go to manage global health’s ‘silent epidemic’? “…Unlike other diseases like HIV and AIDS and tuberculosis — which would need an estimated $22 billion to $24 billion, and $8 billion, respectively, according to statistics released by relevant stakeholders — hepatitis does not yet have a ballpark estimate attached to it. But…More


Fully Funded Phase 4 Trials Necessary To Fill Knowledge Gaps On Malaria Vaccine Effectiveness

BBC News: Malaria vaccine: How good is good enough? Seth Berkely, CEO of Gavi, the Vaccine Alliance, and Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria “How effective does a vaccine have to be before it should be made available? … Such is the question World Health Organization (WHO)…More


Ambitious new U.S. plan may put hundreds of thousands on MDR-TB treatment

Categories: Research and Development, TB, U.S. Policy and FundingThe United States plans to place 360,000 multidrug-resistant tuberculosis patients globally on treatment over the next five years, as part of a national tuberculosis action plan currently under draft. The plan – which is due to be submitted to the White House in September – aims to promote universal MDR-TB treatment, accelerate basic TB research, […](Read more…)


Successes in HIV Overshadow Failures in TB

The world is celebrating a giant milestone in the fight against HIV: 15 million people are now on lifesaving treatment using highly effective antiretroviral drugs! It’s a huge win for global health, and of course for the millions whose lives have been saved.


UNITAID Chair Discusses Innovative Financing In Forbes Interview

Forbes: U.N. Undersecretary Pioneers Invisible Way To End Poverty “U.N. Undersecretary Philippe Douste-Blazy has been on a mission to help people around the world who are suffering beyond comprehension. His UNITAID organization has made material progress raising over $2 billion through micro-levies on airlines tickets that have gone to fight HIV-AIDS, tuberculosis, and malaria. His…More


‘More Pragmatic’ Steps Needed To Reduce TB Risks Among International Travelers

Huffington Post: In The Age Of Travel, Tuberculosis Knows No Borders Sarabjit Chadha, project director at The Union South East Asia; Jamie Tonsing, director at The Union South East Asia; and Paula Fujiwara, scientific director at The Union France “…The risk of [tuberculosis (TB)] transmission during air travel is expected to rise as the number…More


U.S. Secretary Of State Kerry Provides Strong Leadership Critical To Sustaining Global Health…

Huffington Post: The Next Phase of an American Legacy: John Kerry, Global Health, and Financing for Development Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria “…In highlighting U.S. [global health] impact, a common, rarely explored thread emerges: how John Kerry’s steadfast leadership and commitment to global health has significantly…More


Funding Shortage Hurting Indian Government’s TB Program, Leaked Report Says

Reuters: Funding crunch affects India’s fight against TB: report “India’s program to fight tuberculosis is in disarray due to a shortage of funds and the government has failed to meet annual targets to control spread of the nation’s most fatal infectious illness, a leaked assessment report said. … The draft is not in the public…More


Health Aid Disbursement Generally Cost-Effective But Not Always Optimal, Study Shows

Health Affairs: Health Aid Is Allocated Efficiently, But Not Optimally: Insights From A Review Of Cost-Effectiveness Studies Eran Bendavid, assistant professor in the Department of Medicine at Stanford University, and colleagues “reviewed the literature for cost-effectiveness of interventions targeting five disease categories: HIV; malaria; tuberculosis; noncommunicable diseases; and maternal, newborn, and child health. We measured…More


Drug-Resistant TB Threatens India’s Efforts To Control Disease

Scientific American: Supercharged Tuberculosis, Made in India “…Too few diagnostic laboratories, too many poorly trained health practitioners, and thousands of infected people living in crowded, unsanitary conditions has made India home to the world’s largest epidemic of drug-resistant TB. … Yet until recently Indian public health officials remained reluctant to admit there’s a problem…” (Overdorf,…More


MDR-TB More Difficult To Spread Among Close Contacts Than Drug-Susceptible TB, Study Shows

VOA News: Multi-Drug Resistant TB Harder to Spread Among Close Contacts “Incidences of multi-drug resistant tuberculosis (MDR-TB) are increasing, but British and Peruvian researchers are offering a glimmer of hope in the latest issue of PLOS Medicine. Caused by a bacterium that has evolved to become hard to kill with two or more mainstay antibiotics,…More


Global Fund Reforms Provide Lessons For Other International Organizations, Including WHO

Center for Strategic & International Studies: Lessons from the Global Fund’s Reform In this report, Todd Summers, a senior adviser with the CSIS Global Health Policy Center, discusses reforms at the Global Fund to Fight AIDS, Tuberculosis and Malaria, and their lessons for other international organizations, including the WHO (6/24).


Blog Posts Highlight Research Into New Drugs For Malaria, Other Diseases

Global Health Technologies Coalition’s “Breakthroughs”: Research Roundup: a promising antimalarial and leishmaniasis vaccine, diagnostics for tuberculosis, and more Kat Kelley, GHTC’s senior program assistant, highlights recent news in global health research, including the development of an experimental antimalarial drug and a potential leishmaniasis vaccine, clinical trials for new tuberculosis diagnostic tests, and research into pediatric-appropriate…More


Older Posts »